Q2 2023 · 13F-HR
CARNEGIE MELLON UNIVERSITYholdings as filed
Filed 2023-08-01 · accession 0000898432-23-000555
$71.0M
Reported value
6
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 26603R106 | DUOL | DUOLINGO INC | $52.8M | 74.4% | 369,500 | Common | SOLE |
| 46434G103 | IEMG | ISHARES INC | $17.8M | 25.1% | 361,103 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC. | $257,763 | 0.36% | 16,060 | Common | SOLE |
| 64132K102 | — | NEUBASE THERAPEUTICS INC. | $87,834 | 0.12% | 46,970 | Common | SOLE |
| 74039M200 | — | PREDICTIVE ONCOLOGY INC. | $50,340 | 0.07% | 10,358 | Common | SOLE |
| 457919108 | IHT | INNSUITES HOSPITALITY TRUST | $23,900 | 0.03% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.